Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2012, Article ID 380635, 10 pages
Review Article

Gab Adapter Proteins as Therapeutic Targets for Hematologic Disease

1Aflac Cancer Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA 30322, USA
2Aflac Cancer Center and Blood Disorders Service, Division of Hematology-Oncology, Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive NE, ECC 444, Atlanta, GA 30322, USA

Received 14 June 2011; Revised 30 August 2011; Accepted 6 September 2011

Academic Editor: Cheng-Kui Qu

Copyright © 2012 Sheetal Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Tomonori Taniguchi, Shigeru Tanaka, Ayumi Ishii, Miyuki Watanabe, Noriko Fujitani, Ayusa Sugeo, Shuhei Gotoh, Takeshi Ohta, Mineyoshi Hiyoshi, Hideki Matsuzaki, Norio Sakai, and Hiroaki Konishi, “A Brain-specific Grb2-associated Regulator of Extracellular Signal-regulated Kinase (Erk)/Mitogen-activated Protein Kinase (MAPK) (GAREM) Subtype, GAREM2, Contributes to Neurite Outgrowth of Neuroblastoma Cells by Regulating Erk Signaling,” Journal of Biological Chemistry, vol. 288, no. 41, pp. 29934–29942, 2013. View at Publisher · View at Google Scholar
  • Charles Y. F. Young, Kyle M. McKenzie, Graham H. Bevan, Manish Kohli, Donald J. Tindall, Debashis Nandy, and Krishna Vanaja Donkena, “Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer,” OncoTargets and Therapy, vol. 8, pp. 1915–1922, 2015. View at Publisher · View at Google Scholar